when was semaglutide fda approved U.S. | The FDA has a new higher dose (7.2 mg) of Wegovy ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight High-Dose Wegovy Wins FDA Approval

Fasting helps manage eating patterns and supports metabolic health, while semaglutide controls appetite and improves insulin sensitivity

Humira (adalimumab) Disease area(s): Immunology Manufacturer(s): AbbVie 2024 Sales (USD): $8.99 billion Why it sold so well: In 2024, Humira remained a significant revenue contributor for AbbVie, despite facing substantial declines due to biosimilar competition following its US loss of exclusivity in January 2023

Formulary decisions can be made on clinical and net-cost grounds without a competing revenue motive

By enhancing the bodys natural satiety signals and improving metabolic function, tirzepatide helps patients feel full faster, curb cravings, and lose weight more effectively

It is important for patients to take the medication as directed by their healthcare provider to ensure optimal results